Allergan Chief Pyott Assumes Chairmanship
Reuters
Allergan Inc.’s president and chief executive, David E.I. Pyott, has been named to the additional position of chairman, the Irvine company said Wednesday.
Dr. Herbert Boyer, who had been chairman, remains on the board of the company, a maker of drugs for eye and skin care. He also becomes vice chairman, a new position.
Pyott has been chief executive since January 1998.
The stock edged up 10 cents a share to $74.35 on the New York Stock Exchange.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.